Skip to main content
Erschienen in:

21.10.2020 | ORIGINAL ARTICLE

Absolute Resting 13N-Ammonia PET Myocardial Blood Flow for Predicting Myocardial Viability and Recovery of Ventricular Function after Coronary Artery Bypass Grafting

verfasst von: Jiao Wang, Jian-ming Li, Shuai Li, Bailing Hsu

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

We aimed to evaluate the feasibility of resting myocardial blood flow (rMBF), quantified with dynamic 13 N-Ammonia (NH3) PET, for identifying myocardial viability and predicting improvement of left ventricular ejection fraction (LVEF) after coronary artery bypass grafting (CABG).

Methods

Ninety-three patients with coronary artery disease (CAD) and chronic LVEF < 45%, scheduled for CABG, had dynamic 13NH3 PET and 18F-FDG PET imaging. The perfusion/metabolism polar maps were categorized in four patterns: normal (N), mismatch (M1), match (M2) and reverse mismatch (RM). The value of rMBF for identifying viable myocardium (M1, RM) and post CABG improvement of LVEF≥8% was analyzed by receiver operating characteristic (ROC) curves. Correlations of rMBF in segments to ΔLVEF post CABG were verified.

Results

Mean rMBFs were significantly different (N=0.60±0.14; M1=0.44±0.07, M2=0.34±0.08, RM=0.53±0.09 ml/min/g, P<0.001). The optimal rMBF cutoff to identify viable myocardium was 0.42 ml/min/g (sensitivity=88.3%, specificity=82.0%) and 0.43 ml/min/g for predicting improvement of LVEF ≥8% (74.6%, 80.0%). The extent and rMBF of combined M1/RM demonstrated a moderate to high correlation to improved LVEF (r=0.78, 0.71, P<0.001).

Conclusion

Resting MBF, derived by dynamic 13NH3 PET, may be positioned as a supplement to 18F-FDG PET imaging for assessing the presence of viable myocardium and predicting potential improvement of LVEF after CABG.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted in positron tomography. N Engl J Med. 1986;314:884–8.CrossRef Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted in positron tomography. N Engl J Med. 1986;314:884–8.CrossRef
2.
Zurück zum Zitat Nienaber CA, Brunken RC, Sherman CT, et al. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol. 1991;18:966–78.CrossRef Nienaber CA, Brunken RC, Sherman CT, et al. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol. 1991;18:966–78.CrossRef
3.
Zurück zum Zitat Marwick TH, Zuchowski C, Lauer MS, et al. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol. 1999;33(3):750–8.CrossRef Marwick TH, Zuchowski C, Lauer MS, et al. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol. 1999;33(3):750–8.CrossRef
4.
Zurück zum Zitat Vom-Dahl J, Eitzman DT, Al-Aouar ZR, et al. Relation of regional function, perfusion and metabolism in patients with advanced coronary artery diseased undergoing surgical revascularization. Circulation. 1994;90:2356–66.CrossRef Vom-Dahl J, Eitzman DT, Al-Aouar ZR, et al. Relation of regional function, perfusion and metabolism in patients with advanced coronary artery diseased undergoing surgical revascularization. Circulation. 1994;90:2356–66.CrossRef
5.
Zurück zum Zitat Christakis GT, Weisel RD, Fremes SE. Coronary artery bypass grafting in patients with poor ventricular function. J Thorac Cardiovasc Surg. 1993;103:1083–92.CrossRef Christakis GT, Weisel RD, Fremes SE. Coronary artery bypass grafting in patients with poor ventricular function. J Thorac Cardiovasc Surg. 1993;103:1083–92.CrossRef
6.
Zurück zum Zitat Elefteriades JA, Tolis G, Levi E. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival and improved ejection fraction and functional state. J Am Coll Cardiol. 1993;22:1411–7.CrossRef Elefteriades JA, Tolis G, Levi E. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival and improved ejection fraction and functional state. J Am Coll Cardiol. 1993;22:1411–7.CrossRef
7.
Zurück zum Zitat Dreyfus GD, Duboc D, Blasco A, et al. Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg. 1994;57:1402–7.CrossRef Dreyfus GD, Duboc D, Blasco A, et al. Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg. 1994;57:1402–7.CrossRef
8.
Zurück zum Zitat Schinkel AF, Poldermans D, Rizzello V, et al. Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunction. J Nucl Med. 2006;47(1):68–73.PubMed Schinkel AF, Poldermans D, Rizzello V, et al. Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunction. J Nucl Med. 2006;47(1):68–73.PubMed
9.
Zurück zum Zitat Schöder H, Campisi R, Ohtake T, et al. Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction. J Am Coll Cardiol. 1999;33(5):1328–37.CrossRef Schöder H, Campisi R, Ohtake T, et al. Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction. J Am Coll Cardiol. 1999;33(5):1328–37.CrossRef
10.
Zurück zum Zitat Gerber BL, Vanoverschelde JL, Bol A, et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation. 1996;94(4):651–9.CrossRef Gerber BL, Vanoverschelde JL, Bol A, et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation. 1996;94(4):651–9.CrossRef
11.
Zurück zum Zitat Ziadi MC, Dekemp RA, Williams K, et al. Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol. 2012;19:670–80.CrossRef Ziadi MC, Dekemp RA, Williams K, et al. Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol. 2012;19:670–80.CrossRef
12.
Zurück zum Zitat Maddahi J, Packard RRS. PET should replace SPECT in cardiac imaging for diagnosis and risk assessment of patients with known or suspected. CAD: Pro J Nucl Cardiol. 2017;24(6):1955–9.PubMed Maddahi J, Packard RRS. PET should replace SPECT in cardiac imaging for diagnosis and risk assessment of patients with known or suspected. CAD: Pro J Nucl Cardiol. 2017;24(6):1955–9.PubMed
13.
Zurück zum Zitat Al-Badarin F, Aljizeeri A, Almasoudi F, et al. Assessment of myocardial blood flow and coronary flow reserve with positron emission tomography in ischemic heart disease: current state and future directions. Heart Fail Rev. 2017;22(4):441–3.CrossRef Al-Badarin F, Aljizeeri A, Almasoudi F, et al. Assessment of myocardial blood flow and coronary flow reserve with positron emission tomography in ischemic heart disease: current state and future directions. Heart Fail Rev. 2017;22(4):441–3.CrossRef
14.
Zurück zum Zitat Fiechter M, Ghadri JR, Gebhard C, et al. Diagnostic value of 13 N-ammonia myocardial perfusion PET: added value of myocardial flow reserve. J Nucl Med. 2012;53(8):1230–4.CrossRef Fiechter M, Ghadri JR, Gebhard C, et al. Diagnostic value of 13 N-ammonia myocardial perfusion PET: added value of myocardial flow reserve. J Nucl Med. 2012;53(8):1230–4.CrossRef
15.
Zurück zum Zitat Herzog BA, Husmann L, Valenta I, et al. Long-term prognostic value of 13 N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol. 2009;54:150–6.CrossRef Herzog BA, Husmann L, Valenta I, et al. Long-term prognostic value of 13 N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol. 2009;54:150–6.CrossRef
16.
Zurück zum Zitat Tawakol A, Skopicki HA, Abraham SA, et al. Evidence of reduce resting blood flow in viable myocardial regions with chronic asynergy. J Am Coll Cardiol. 2000;36:2146–53.CrossRef Tawakol A, Skopicki HA, Abraham SA, et al. Evidence of reduce resting blood flow in viable myocardial regions with chronic asynergy. J Am Coll Cardiol. 2000;36:2146–53.CrossRef
17.
Zurück zum Zitat Prato FS, Butler J, Sykes J, et al. Can the inflammatory response be evaluated using 18F-FDG within zones of microvascular obstruction after myocardial infarction? J Nucl Med. 2015 Feb;56(2):299–304.CrossRef Prato FS, Butler J, Sykes J, et al. Can the inflammatory response be evaluated using 18F-FDG within zones of microvascular obstruction after myocardial infarction? J Nucl Med. 2015 Feb;56(2):299–304.CrossRef
18.
Zurück zum Zitat Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensionalechocardiography. American Society of Echocardiography Committee onStandards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2(5):358–67.CrossRef Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensionalechocardiography. American Society of Echocardiography Committee onStandards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2(5):358–67.CrossRef
19.
Zurück zum Zitat Dorbala S, DiCarli MF, Delbeke D, et al. SNMMI/ASNC/SCCT Guideline for Cardiac SPECT/CT and PET/CT 1.0. J Nucl Med. 2013;54(8):1485.CrossRef Dorbala S, DiCarli MF, Delbeke D, et al. SNMMI/ASNC/SCCT Guideline for Cardiac SPECT/CT and PET/CT 1.0. J Nucl Med. 2013;54(8):1485.CrossRef
20.
Zurück zum Zitat Vennart NJ, Bird N, Buscombe J, et al. Optimization of PET/CT image quality using the GE ‘Sharp IR’ point-spread function reconstruction algorithm. Nucl Med Commun. 2017;38(6):471–9.CrossRef Vennart NJ, Bird N, Buscombe J, et al. Optimization of PET/CT image quality using the GE ‘Sharp IR’ point-spread function reconstruction algorithm. Nucl Med Commun. 2017;38(6):471–9.CrossRef
21.
Zurück zum Zitat Slomka PJ, Alexanderson E, Jácome R, et al. Comparison of clinical tools for measurements of regional stress and rest myocardial blood flow assessed with 13 N-ammonia PET/CT. J Nucl Med. 2012;53(2):171–81.CrossRef Slomka PJ, Alexanderson E, Jácome R, et al. Comparison of clinical tools for measurements of regional stress and rest myocardial blood flow assessed with 13 N-ammonia PET/CT. J Nucl Med. 2012;53(2):171–81.CrossRef
22.
Zurück zum Zitat Dorbala S, Ananthasubramaniam K, Armstrong IS, et al. Single photon emission computed tomography (SPECT) myocardial perfusion imaging guidelines: instrumentation, acquisition, processing, and interpretation. J Nucl Cardiol. 2018;25(5):1784–846.CrossRef Dorbala S, Ananthasubramaniam K, Armstrong IS, et al. Single photon emission computed tomography (SPECT) myocardial perfusion imaging guidelines: instrumentation, acquisition, processing, and interpretation. J Nucl Cardiol. 2018;25(5):1784–846.CrossRef
23.
Zurück zum Zitat Dilsizian V, Bacharach SL, Beanlands RS. ASNC Imaging Guidelines for Nuclear Cardiology Procedures: Standardized Reporting of Radionuclide Myocardial Perfusion and Function http://www.asnc.org July 2009. Dilsizian V, Bacharach SL, Beanlands RS. ASNC Imaging Guidelines for Nuclear Cardiology Procedures: Standardized Reporting of Radionuclide Myocardial Perfusion and Function http://​www.​asnc.​org July 2009.
24.
Zurück zum Zitat Müller-Ehmsen J, Tossios P, Schmidt M, et al. Transmurality of scar influences the effect of a hybrid-intervention with autologous bone marrow cell injection and aortocoronary bypass surgery (MNC/CABG) in patients after myocardial infarction. Int. J. Cardiol. 2012;156(3):303–8.CrossRef Müller-Ehmsen J, Tossios P, Schmidt M, et al. Transmurality of scar influences the effect of a hybrid-intervention with autologous bone marrow cell injection and aortocoronary bypass surgery (MNC/CABG) in patients after myocardial infarction. Int. J. Cardiol. 2012;156(3):303–8.CrossRef
25.
Zurück zum Zitat Gewirtz H, Fischman AJ, Abraham S, et al. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J. Am. Coll. Cardiol. 1994;23(4):851–9.CrossRef Gewirtz H, Fischman AJ, Abraham S, et al. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J. Am. Coll. Cardiol. 1994;23(4):851–9.CrossRef
26.
Zurück zum Zitat Aramayo Gerónimo EN, Osorio AR, Geronazzo RJ, et al. Relationship between myocardial viability, myocardial flow and coronary anatomy by positron emission tomography integrated with multislice computed tomography. Rev Argent Cardiol. 2013;81:113–8.CrossRef Aramayo Gerónimo EN, Osorio AR, Geronazzo RJ, et al. Relationship between myocardial viability, myocardial flow and coronary anatomy by positron emission tomography integrated with multislice computed tomography. Rev Argent Cardiol. 2013;81:113–8.CrossRef
27.
Zurück zum Zitat Beanlands RS, deKemp R, Scheffel A, et al. Can nitrogen-13 Ammonia kinetic modeling define myocardial viability independent of Fluorine-18 fluorodeoxyglucose? J Am Coll Cardiol. 1997;29(3):537–43.CrossRef Beanlands RS, deKemp R, Scheffel A, et al. Can nitrogen-13 Ammonia kinetic modeling define myocardial viability independent of Fluorine-18 fluorodeoxyglucose? J Am Coll Cardiol. 1997;29(3):537–43.CrossRef
29.
Zurück zum Zitat Zhang X, Schindler TH, Prior JO, et al. Blood flow, flow reserve, and glucose utilization in viable and nonviable myocardium in patients with ischemic cardiomyopathy. Eur J Nucl Med Mol Imaging. 2013;40(4):532–41.CrossRef Zhang X, Schindler TH, Prior JO, et al. Blood flow, flow reserve, and glucose utilization in viable and nonviable myocardium in patients with ischemic cardiomyopathy. Eur J Nucl Med Mol Imaging. 2013;40(4):532–41.CrossRef
30.
Zurück zum Zitat Beanlands RS, Ruddy TD, deKemp RA, et al. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol. 2002;40(10):1735–43.CrossRef Beanlands RS, Ruddy TD, deKemp RA, et al. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol. 2002;40(10):1735–43.CrossRef
Metadaten
Titel
Absolute Resting 13N-Ammonia PET Myocardial Blood Flow for Predicting Myocardial Viability and Recovery of Ventricular Function after Coronary Artery Bypass Grafting
verfasst von
Jiao Wang
Jian-ming Li
Shuai Li
Bailing Hsu
Publikationsdatum
21.10.2020
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 3/2022
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-020-02388-7

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Kardiologie

Risiko für Optikusneuropathie unter Semaglutid in Studie erhöht

In einer retrospektiven Kohortenstudie war das Risiko, eine bestimmte Form von Optikusneuropathie zu entwickeln, bei Diabeteskranken unter Semaglutid erhöht. Das Studiendesign gibt allerdings Anlass zu Zweifeln.

Neuer Score zeigt: Wer profitiert wirklich von der TAVI?

Die Risikoscores, die derzeit zur Indikationsstellung einer TAVI herangezogen werden sollten, sind nicht spezifisch für die TAVI evaluiert worden. Ein neuer Score ist präziser, doch kann er sich in der Praxis durchsetzen?

Vergessen Sie nicht Lp(a) zu messen!

Neue Therapien zur Senkung erhöhter Lp(a)-Spiegel sind in der Entwicklung, aber (noch) nicht verfügbar. Dennoch gibt es in der Praxis schon jetzt gute Gründe, bei einem Menschen den Lp(a)-Wert mindestens einmal im Leben zu bestimmen.

Lipidtherapie im Praxisalltag: Noch viel Spielraum für Verbesserung

Wie steht es um die Behandlung von Dyslipidämien bei Risikopatienten mit atherosklerotischer Gefäßerkrankung in Deutschland? Eine Bestandsaufnahme dazu liefert das bei der DGK-Tagung 2025 vorgestellte Forschungsprojekt LipidSnapshot.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.